BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33879535)

  • 1. Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes.
    Colato E; Stutters J; Tur C; Narayanan S; Arnold DL; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O; Chard DT; Eshaghi A
    J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):995-1006. PubMed ID: 33879535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Networks of microstructural damage predict disability in multiple sclerosis.
    Colato E; Prados F; Stutters J; Bianchi A; Narayanan S; Arnold DL; Wheeler-Kingshott C; Barkhof F; Ciccarelli O; Chard DT; Eshaghi A
    J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):992-1003. PubMed ID: 37468305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
    Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
    Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.
    Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA
    Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort.
    de Ruiter LRJ; Loonstra FC; Jelgerhuis JR; Coerver EME; Toorop AA; van Leeuwen ICE; Noteboom S; Moraal B; Strijbis EMM; Schoonheim MM; Uitdehaag BMJ
    Mult Scler Relat Disord; 2023 Mar; 71():104568. PubMed ID: 36805177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of single-subject grey matter networks in early multiple sclerosis.
    Fleischer V; Gonzalez-Escamilla G; Pareto D; Rovira A; Sastre-Garriga J; Sowa P; Høgestøl EA; Harbo HF; Bellenberg B; Lukas C; Ruggieri S; Gasperini C; Uher T; Vaneckova M; Bittner S; Othman AE; Collorone S; Toosy AT; Meuth SG; Zipp F; Barkhof F; Ciccarelli O; Groppa S
    Brain; 2024 Jan; 147(1):135-146. PubMed ID: 37642541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain grey matter perfusion in primary progressive multiple sclerosis: Mild decrease over years and regional associations with cognition and hand function.
    Testud B; Delacour C; El Ahmadi AA; Brun G; Girard N; Duhamel G; Heesen C; Häußler V; Thaler C; Has Silemek AC; Stellmann JP
    Eur J Neurol; 2022 Jun; 29(6):1741-1752. PubMed ID: 35167161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis.
    Koch MW; Mostert J; Repovic P; Bowen JD; Strijbis E; Uitdehaag B; Cutter G
    Mult Scler; 2022 Apr; 28(4):561-572. PubMed ID: 34304609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting clinical progression in multiple sclerosis after 6 and 12 years.
    Dekker I; Eijlers AJC; Popescu V; Balk LJ; Vrenken H; Wattjes MP; Uitdehaag BMJ; Killestein J; Geurts JJG; Barkhof F; Schoonheim MM
    Eur J Neurol; 2019 Jun; 26(6):893-902. PubMed ID: 30629788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Damage Predicts Clinical Worsening in Multiple Sclerosis: A 6.4-Year Study.
    Rocca MA; Valsasina P; Meani A; Pagani E; Cordani C; Cervellin C; Filippi M
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34021055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of daily occupations in multiple sclerosis: analysis of neuroimaging, general and social cognition, and reserve.
    Gomes LR; Damasceno BP; de Campos BM; Damasceno A
    Mult Scler Relat Disord; 2024 Jan; 81():105140. PubMed ID: 37988860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic gray matter volume changes in pediatric multiple sclerosis: A 3.5 year MRI study.
    De Meo E; Meani A; Moiola L; Ghezzi A; Veggiotti P; Filippi M; Rocca MA
    Neurology; 2019 Apr; 92(15):e1709-e1723. PubMed ID: 30867274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairments in Walking Ability, Dexterity, and Cognitive Function in Multiple Sclerosis Are Associated with Different Regional Cerebellar Gray Matter Loss.
    Grothe M; Lotze M; Langner S; Dressel A
    Cerebellum; 2017 Dec; 16(5-6):945-950. PubMed ID: 28612183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.
    Jakimovski D; Weinstock-Guttman B; Hagemeier J; Vaughn CB; Kavak KS; Gandhi S; Bennett SE; Fuchs TA; Bergsland N; Dwyer MG; Benedict RHB; Zivadinov R
    J Neurol Sci; 2018 Oct; 393():128-134. PubMed ID: 30165291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.
    Sbardella E; Petsas N; Tona F; Prosperini L; Raz E; Pace G; Pozzilli C; Pantano P
    PLoS One; 2013; 8(5):e63250. PubMed ID: 23696802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.